Hydrocodone bitartrate

Hydrocodone Bitartrate is the bitartrate salt form of hydrocodone, a semisynthetic hydrogenated codeine derivative and opioid agonist with analgesic and antitussive effects. Hydrocodone mainly binds to and activates the mu-opioid receptor in the central nervous system (CNS). This leads to analgesia, euphoria, respiratory depression, miosis, decreased gastrointestinal motility, cough suppression and physical dependence. Hydrocodone is converted to hydromorphone by the cytochrome P450 enzyme CYP2D6. It is grouped under the following drug class(es): Antitussives and Controlled drug substances. Its therapeutic use is listed as analgesics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Mercodinone, Zohydro ER, Hysingla, Vantrela and Dihydrocodeinone bitartrate hydrate. It is listed as a controlled drug substance (Schedule II). Its PubChem CID is 23724881.

CAS No 34195-34-1
Molecular Formula C44H64N2O23
Molecular Weight 989.0 g/mol
Synonyms bis((4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one);bis((2R,3R)-2,3-dihydroxybutanedioic acid);pentahydrate

Frequently Asked Questions